Effect of beraprost Sodium on Prognosis of Patients with Acute ST Elevation Myocardial Infarction
Objective To evaluate the effect of beraprost sodium on the prognosis of patients with acute ST segment elevation myo-cardial infarction(STEMI).Method 90 patients with STEMI who were treated in Shenzhen People's Hospital from August 2019 to De-cember 2021 were randomly selected as research object.They were randomly divided into:45 patients in the beraprost sodium group;45 cases in the control group.Compare the main adverse events(MACE),target vessel revascularization,and incidence of cardiac death within 1 month and 12 months after surgery in each group.Results The incidence of MACE,target vessel revascularization,and cardi-ac death within one month after surgery,as well as the incidence of cardiac death at 12 months after surgery,were statistically signifi-cant(P<0.05).There was no statistically significant difference in MACE and target vessel revascularization within 12 months after surgery(P>0.05).Conclusion Beraprost sodium can reduce the incidence of MACE,target vessel revascularization and cardiac death within one month after operation,and reduce the incidence of cardiac death within 12 months after operation.
Beraprost sodiumAcute ST segment elevation myocardial infarctionPrognosis
万方数据
维普
